Haploidentical allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma in the era of novel agents: a single-center experience

Leukemia & lymphoma/Leukemia and lymphoma 2026

View at publisher
Authors: Alessio Maria Edoardo Maraglino, Simona Sammassimo, Alice Clemente, Anna Vanazzi, Ginevra Lolli, Tommaso Radice, Paulina Maria Nierychlewska, Michele Sorrenti, Simonetta Viviani, Rocco Pastano, Corrado Tarella, Enrico Derenzini
DOI: 10.1080/10428194.2026.2639056
Cited by: 0
References: 15

Abstract

Classical Hodgkin Lymphoma (cHL) can be treated successfully with standard chemotherapy and/or radiotherapy, with an excellent prognosis and an estimated 10-year survival rate of more than 80% [1]....

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Lymphoma Diagnosis and Treatment Immunodeficiency and Autoimmune Disorders

Publication details

Journal / source
Leukemia & lymphoma/Leukemia and lymphoma
Volume
67
Issue
7
Pages
1650–1654
Publication date
4 March 2026
Language
EN